BioCryst Pharmaceuticals, Inc. (BCRX)
7.68
+0.03
(+0.39%)
USD |
NASDAQ |
Nov 12, 16:00
7.65
-0.03
(-0.39%)
After-Hours: 20:00
BioCryst Pharmaceuticals Market Cap : 1.967B for Nov. 12, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 1.967B |
| November 11, 2026 | 1.959B |
| November 10, 2026 | 1.929B |
| November 09, 2026 | 1.954B |
| November 06, 2026 | 1.970B |
| November 05, 2026 | 1.954B |
| November 04, 2026 | 2.110B |
| November 03, 2026 | 2.195B |
| November 02, 2026 | 2.112B |
| October 30, 2026 | 2.162B |
| October 29, 2026 | 2.175B |
| October 28, 2026 | 2.137B |
| October 27, 2026 | 2.068B |
| October 26, 2026 | 2.011B |
| October 23, 2026 | 1.953B |
| October 22, 2026 | 1.986B |
| October 21, 2026 | 1.978B |
| October 20, 2026 | 2.027B |
| October 19, 2026 | 2.060B |
| October 16, 2026 | 1.989B |
| October 15, 2026 | 2.047B |
| October 14, 2026 | 2.055B |
| October 13, 2026 | 2.060B |
| October 12, 2026 | 2.134B |
| October 09, 2026 | 2.183B |
| Date | Value |
|---|---|
| October 08, 2026 | 2.116B |
| October 07, 2026 | 2.144B |
| October 06, 2026 | 2.029B |
| October 05, 2026 | 2.068B |
| October 02, 2026 | 2.086B |
| October 01, 2026 | 2.073B |
| September 30, 2026 | 2.126B |
| September 29, 2026 | 2.111B |
| September 28, 2026 | 2.162B |
| September 25, 2026 | 2.193B |
| September 24, 2026 | 2.175B |
| September 23, 2026 | 2.188B |
| September 22, 2026 | 2.241B |
| September 21, 2026 | 2.236B |
| September 18, 2026 | 2.216B |
| September 17, 2026 | 2.221B |
| September 16, 2026 | 2.152B |
| September 15, 2026 | 2.083B |
| September 14, 2026 | 2.101B |
| September 11, 2026 | 2.073B |
| September 10, 2026 | 2.116B |
| September 09, 2026 | 2.248B |
| September 08, 2026 | 2.314B |
| September 04, 2026 | 2.542B |
| September 03, 2026 | 2.576B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 252.63B |
| Halozyme Therapeutics, Inc. | 11.47B |
| Neurocrine Biosciences, Inc. | 17.16B |
| Agenus, Inc. | 310.58M |
| Anika Therapeutics, Inc. | 184.97M |
Market Cap Related Metrics
| PS Ratio | 1.986 |
| PEG Ratio | -0.0019 |
| Price to Free Cash Flow | 5.471 |
| Price | 7.68 |
| Earnings Yield | -18.50% |
| PEGY Ratio | -0.0019 |
| Operating PE Ratio | 4.675 |
| Normalized PE Ratio | 12.14 |